A blog about what is new (and old) in the world of active implantable medical devices

Neuralink raises $650 million Series E to further develop and expand use of their BCI

Posted on by Posted in Brain-Computer Interface, Neuralink
Neuralink implant

Image credit: Neuralink

Neuralink announced that it has raised $650M in series F which will be used to further develop their BCI system and expand the number of patients in their clinical trials.

The announcement mentioned the following recent advancements:

  • “Welcoming our first pioneers: Five individuals with severe paralysis are now using Neuralink to control digital and physical devices with their thoughts, marking a profound step toward helping restore independence.

  • Launching global clinical trials: We launched clinical trials at leading institutions for neurosurgical care spanning three countries and two continents, including Barrow Neurological Institute, The Miami Project to Cure Paralysis at the University of Miami, University Health Network (Toronto Western Hospital), and Cleveland Clinic Abu Dhabi.

  • Pursuing new applications: We paved the way for applying Neuralink technology to use cases beyond digital device control by launching the CONVOY trial and securing FDA Breakthrough Device Designation for both innovative vision and speech restoration programs.

  • Progressing towards a whole-brain interface: We have invested heavily in expanding the number of neurons and brain regions that our device interfaces with to unlock new dimensions of human potential.”